On September 10, 2025, Dogecoin Cash, Inc. ($CBDS), a key player in blockchain technology, revealed that its subsidiary PrestoDoctor, a top telemedicine platform for medical cannabis evaluations, has initiated the acceptance of cryptocurrency payments. This new option includes various digital assets, notably Dogecoin (DOGE). Dogecoin Cash, Inc. aims to integrate decentralized technologies and provide patients with a more modern healthcare experience. CEO David Tobias stated that by embracing cryptocurrencies like Dogecoin, PrestoDoctor is adapting to the changing preferences of its patient base.